Comparing light sedation during clot removal for stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares two types of light sedation (medication to help you relax) during a procedure to remove a blood clot in the brain after a stroke. The goal is to find which sedation method helps patients recover better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having a stroke caused by a clot in a large artery in the front part of your brain.
- You can be treated within 24 hours of your stroke starting.
- You were able to do your daily activities independently before this stroke.
- Your stroke symptoms are moderate to severe (a score of 6 or more on a stroke scale).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different types of calming medicine (sedation) after a procedure to remove a brain blood clot. It aims to see whether post-procedure sedation can improve recovery in people with a serious type of stroke.
This Phase 4 study tests whether using a specific calming medicine (dexmedetomidine) for a longer period after a successful clot-removal procedure helps people do better in the long term. It may help improve outcomes after ischemic stroke where the clot is successfully treated.
This trial compares two methods for removing blood clots from arteries in the brain during an acute stroke: aspiration (suction) versus stent retriever (a mesh device). The goal is to see which approach works better for patients treated within 24 hours of stroke symptoms.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This trial tests if a sublingual (under the tongue) medication called Edaravone Dexborneol can help stroke patients who are being transferred from one hospital to another for a specialized procedure to remove a clot.
This trial compares different scan choices to help doctors decide the best approach for removing a stroke clot. It aims to improve outcomes after emergency stroke treatment by using the right imaging information.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.